<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0036-3634</journal-id>
<journal-title><![CDATA[Salud Pública de México]]></journal-title>
<abbrev-journal-title><![CDATA[Salud pública Méx]]></abbrev-journal-title>
<issn>0036-3634</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Salud Pública]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0036-36342003000100008</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Coordination of international multicenter studies: governance and administrative structure]]></article-title>
<article-title xml:lang="es"><![CDATA[Coordinación de estudios multicéntricos internacionales: estructura administrativa y reglamentación]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bangdiwala]]></surname>
<given-names><![CDATA[Shrikant I.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Paula]]></surname>
<given-names><![CDATA[Cristiane S. de]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramiro]]></surname>
<given-names><![CDATA[Laurie S.]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[Sergio R.]]></given-names>
</name>
<xref ref-type="aff" rid="A04"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,University of North Carolina  ]]></institution>
<addr-line><![CDATA[Chapel Hill NC]]></addr-line>
<country>USA</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Universidade Federal de São Paulo Escola Paulista de Medicina ]]></institution>
<addr-line><![CDATA[São Paulo ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="A03">
<institution><![CDATA[,University of the Philippines  ]]></institution>
<addr-line><![CDATA[Manila ]]></addr-line>
<country>The Philippines</country>
</aff>
<aff id="A04">
<institution><![CDATA[,Universidad de La Frontera  ]]></institution>
<addr-line><![CDATA[Temuco ]]></addr-line>
<country>Chile</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>01</month>
<year>2003</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>01</month>
<year>2003</year>
</pub-date>
<volume>45</volume>
<numero>1</numero>
<fpage>58</fpage>
<lpage>66</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0036-36342003000100008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0036-36342003000100008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0036-36342003000100008&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[A well-conducted multicenter study needs to assure standardization, uniformity of procedures, high data quality, and collaboration across sites. This manuscript describes the organization and dynamics of multicenter studies, focusing on governance and administrative structures among countries of diverse cultures. The organizational structure of a multicenter study is described, and a system for oversight and coordination, along with roles and responsibilities of participants in the multicenter study, are presented. The elements of a governance document are also reviewed, along with guidelines and policies for effective collaboration. The experience of an ongoing multi-country collaboration, the World Studies of Abuse in the Family Environment (WorldSAFE), illustrates the implementation of these guidelines. It is essential that multicenter studies have an objective coordinating center and that the investigators jointly develop a written governance document to enable collaboration and preserve collegiality among participating investigators.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[La ejecución de estudios multicéntricos requiere el establecimiento de procedimientos uniformes, control de calidad, asegurar estandarización, y la colaboración entre las instituciones participantes. Este trabajo describe la estructura y la dinámica de los estudios multicéntricos internacionales, enfocando los aspectos de administración y reglamentación. Se describe la estructura organizativa de un estudio multicéntrico, así como los roles de los integrantes de un sistema de supervisión y coordinación. Se presentan los elementos de un documento de reglamentación y se describen algunas guías y políticas para una colaboración eficaz. La experiencia del estudio internacional colaborativo World Studies of Abuse in the Family Environment (WorldSAFE) se utiliza como ejemplo de la aplicación de estas normas. Un centro de coordinación estadística, así como un documento de auto-reglamentación son elementos esenciales para establecer y mantener la colaboración de las diferentes instituciones que participan en un estudio multicéntrico.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[multicenter studies]]></kwd>
<kwd lng="en"><![CDATA[organization and administration]]></kwd>
<kwd lng="en"><![CDATA[epidemiologic studies]]></kwd>
<kwd lng="en"><![CDATA[clinical trials]]></kwd>
<kwd lng="es"><![CDATA[estudios multicéntricos]]></kwd>
<kwd lng="es"><![CDATA[organización y administración]]></kwd>
<kwd lng="es"><![CDATA[estudios epidemiológicos]]></kwd>
<kwd lng="es"><![CDATA[ensayos clínicos]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">ART&Iacute;CULO    DE REVISI&Oacute;N</font></b></p>     <p align="right">&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="4"><a name="top1"></a>Coordination    of international multicenter studies: Governance and administrative structure</font></b></p>     <p>&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="3">Coordinaci&oacute;n    de estudios multic&eacute;ntricos internacionales: estructura administrativa    y reglamentaci&oacute;n</font></b></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Shrikant    I. Bangdiwala, PhD<sup>I, <a href="#back1">1</a></sup>; Cristiane S. de Paula,    MS<sup>II, <a href="#back2">2</a></sup>; Laurie S. Ramiro, PhD<sup>III, <a href="#back3">3</a></sup>;    Sergio R. Mu&ntilde;oz, PhD<sup>IV, <a href="#back4">4</a></sup>; </font></b></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><sup>I</sup>University    of North Carolina, Chapel Hill, NC, USA    <br>   </font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><sup>II</sup>Escola    Paulista de Medicina, Universidade Federal de S&atilde;o Paulo, S&atilde;o Paulo,    Brazil    ]]></body>
<body><![CDATA[<br>   </font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><sup>III</sup>University    of the Philippines, Manila, The Philippines</font>    <br>   <font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><sup>IV</sup>Universidad    de La Frontera, Temuco, Chile</font></p>     <p>&nbsp;</p>     <p>&nbsp;</p> <hr size="1" noshade>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">ABSTRACT</font></b></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">A well-conducted    multicenter study needs to assure standardization, uniformity of procedures,    high data quality, and collaboration across sites. This manuscript describes    the organization and dynamics of multicenter studies, focusing on governance    and administrative structures among countries of diverse cultures. The organizational    structure of a multicenter study is described, and a system for oversight and    coordination, along with roles and responsibilities of participants in the multicenter    study, are presented. The elements of a governance document are also reviewed,    along with guidelines and policies for effective collaboration. The experience    of an ongoing multi-country collaboration, the World Studies of Abuse in the    Family Environment (WorldSAFE), illustrates the implementation of these guidelines.    It is essential that multicenter studies have an objective coordinating center    and that the investigators jointly develop a written governance document to    enable collaboration and preserve collegiality among participating investigators.    The English version of this paper is available too at: <a href="http://www.insp.mx/salud/index.html">http://www.insp.mx/salud/index.html</a></font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><b>Key words:</b>    multicenter studies; organization and administration; epidemiologic studies;    clinical trials</font></p> <hr size="1" noshade>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">RESUMEN</font></b></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">La ejecuci&oacute;n    de estudios multic&eacute;ntricos requiere el establecimiento de procedimientos    uniformes, control de calidad, asegurar estandarizaci&oacute;n, y la colaboraci&oacute;n    entre las instituciones participantes. Este trabajo describe la estructura y    la din&aacute;mica de los estudios multic&eacute;ntricos internacionales, enfocando    los aspectos de administraci&oacute;n y reglamentaci&oacute;n. Se describe la    estructura organizativa de un estudio multic&eacute;ntrico, as&iacute; como    los roles de los integrantes de un sistema de supervisi&oacute;n y coordinaci&oacute;n.    Se presentan los elementos de un documento de reglamentaci&oacute;n y se describen    algunas gu&iacute;as y pol&iacute;ticas para una colaboraci&oacute;n eficaz.    La experiencia del estudio internacional colaborativo World Studies of Abuse    in the Family Environment (WorldSAFE) se utiliza como ejemplo de la aplicaci&oacute;n    de estas normas. Un centro de coordinaci&oacute;n estad&iacute;stica, as&iacute;    como un documento de auto-reglamentaci&oacute;n son elementos esenciales para    establecer y mantener la colaboraci&oacute;n de las diferentes instituciones    que participan en un estudio multic&eacute;ntrico. El texto completo en ingl&eacute;s    de este art&iacute;culo tambi&eacute;n est&aacute; disponible en: <a href="http://www.insp.mx/salud/index.html">http://www.insp.mx/salud/index.html</a></font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><b>Palabras    clave:</b> estudios multic&eacute;ntricos; organizaci&oacute;n y administraci&oacute;n;    estudios epidemiol&oacute;gicos; ensayos cl&iacute;nicos</font></p> <hr size="1" noshade>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Every research    study requires a sound design, careful planning, good management, and proper    analysis. In some cases, a study is conducted in multiple sites due to sample    size considerations, the desire to explore differences among sites, or for enabling    generalization of results across sites. It should be noted that there is a distinction    between <i>multi-site</i> studies and <i>multicenter</i> studies. In both types    of studies, multiple institutions perform the same procedures as others. However,    in multi-site studies, the investigators at the sites do not participate as    co-investigators of the study; they are merely carrying out the study (e.g.    recruiting subjects, treating subjects, and/or following subjects) and thus    can be viewed as contractors. On the other hand, in a multicenter study, the    investigators at the sites are involved as co-investigators in the planning    of the study protocol and procedures, are scientifically responsible for the    study results, and participate in manuscripts and other dissemination activities.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">This paper    presents the organizational structure for a multicenter study that is international,    discussing the roles and functioning of the participating centers and committees.    The elements of a governance document and of publication guidelines are also    presented. The World Studies of Abuse in the Family Environment<sup>1</sup>    are used as an example on the feasibility of implementing the ideas of a coordinating    center, oversight for a study, and governance documents internationally.</font></p>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Organizational    structure of multicenter studies</font></b></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">In a multicenter    study, it is necessary that the activities be shared among the principal investigators    from each of the participating centers. Each must feel scientifically responsible    and accountable for the integrity of the study.<sup>2</sup> Oversight and policy    making in such studies is provided by the Steering Committee (SC), composed    of the principal investigators of each participating center. Depending on the    complexity of the study, there may be other central agencies (e.g. central laboratories,    event adjudication committees) or external committees (e.g. data and safety    monitoring board, technical advisory committee, sponsor).</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">If a study    is conducted in multiple sites, a major effort is necessary for assuring standardization    and uniformity across sites. In such studies, it is necessary to have an independent    group, not one of the sites, to be held responsible for assuring and monitoring    the proper conduct of the study.<sup>3</sup> This institution is called the    Statistical Coordinating Center (CC). The roles of the CC are two-fold: overall    study coordination and management, and statistical data management coordination.    Though not commonly done, in some cases, one institution may perform the administrative    tasks of the CC while another institution is in charge of the statistical and    data handling tasks.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The typical    organizational structure can be explained by grouping the roles into three levels:    oversight level (Sponsor and Steering Committee), coordination level (Coordinating    Center and other Centralized Agencies) and conduct level (Site specific) &#150 see    <a href="#figura1">figure 1</a>.</font></p>     <p align="center"><a name="figura1"></a></p>     <p align="center">&nbsp;</p>     ]]></body>
<body><![CDATA[<p align="center"><img src="/img/revistas/spm/v45n1/15051f1.gif"></p>     <p align="center">&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">For example,    the World Studies of Abuse in the Family Environment (WorldSAFE) is a multi-center    observational study whose primary objective is to investigate child and spousal    abuse that occurs within families in different cultures across a variety of    countries. To date, five countries are involved: Brazil, Chile, Egypt, India    and Philippines, and the study is still recruiting new sites. <a href="#figura2">Figure    2</a> describes the organizational structure of WorldSAFE. There are a total    of 11 sites participating, with one site per country except for India, which    received additional country-specific funding and thus was able to maintain the    seven separate sites. Because of the multiple sites within India, there is a    separate coordinating center for Indian sites.</font></p>     <p align="center"><a name="figura2"></a></p>     <p align="center">&nbsp;</p>     <p align="center"><img src="/img/revistas/spm/v45n1/15051f2.gif"></p>     <p align="center">&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><i>Oversight    level</i></font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">All studies,    whether at a single site or multi-site, require overall guidance and a policy-making    group. Single site studies have one person typically responsible for this activity,    the study principal investigator (PI). However, multicenter studies involving    multiple PIs must unite the various investigators into a policy issuing/governing    group. In addition to internal oversight, external oversight from advisory boards    and the study sponsor are often part of the study.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The study    steering committee (SC) is responsible for providing the overall guidance for    the study, setting policy, and for the dissemination of study results. Since    this group is scientifically responsible for all study decisions, the members    of the SC should include representation from each study institution, from sites    as well as from centralized agencies. Although an institution may have two or    more investigators on the committee, typically the one voting member per institution    is the principal investigator.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">It is often    difficult for the SC to meet frequently, an issue that is more challenging for    studies done internationally. Depending on the size of the committee, and of    the financial status of the study, the SC may elect to hold conference calls,    or communicate frequently on decision making issues via electronic mail, a secure    web server, closed chat rooms, or other rapid systems such as faxes or courier    services. However, there is always a need for face-to-face communication and    discussion of issues, and it may be necessary for a subset of the SC to be designated    as an Executive Subcommittee, a much smaller group of usually 3-5 individuals    for more frequent interaction. Conference calls, though costly, are cheaper    than in-person meetings and especially useful for multi-country studies.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The SC,    again depending on its size, often also surrounds itself with various subcommittees    to develop and monitor study activities (e.g. recruitment, measures, publications,    data handling, etc.). These subcommittees function as advisors to the SC, i.e.    they meet more frequently to study issues in depth, elaborate proposed policies,    present them to the full SC for ultimate decision taking, and monitor the implementation    of the policies.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">For example,    the WorldSAFE Steering Committee is composed of the principal investigators    of the countries, of the coordinating centers, and of two out of the four external    consultants to the study. The investigators in India have also a country-specific    steering committee. Neither is large enough to have subcommittees.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The study    sponsor also provides some oversight, but is responsible primarily for financial    support. The sponsor can be a government agency, a private industry organization,    a volunteer non-profit organization, a charitable foundation, or a third-party    payer. The sponsor may be invited to participate in providing oversight to the    study investigators, may be solely relegated to being a financial provider,    or may take an active role in the oversight of the study. The different levels    of involvement of the sponsor depend on the desires of the study investigators    or of the sponsor, and of the acceptability by the scientific community of their    participation.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">In many    studies, an independent group of advisors external to the study institutions    is formed to provide oversight and guidance. In addition, in clinical trials    where ethical considerations from conducting an experiment dictate the needs,    a data and safety monitoring board (DSMB) is often mandatory. The DSMB members    include investigators, biostatisticians, and ethicists that are not from any    of the study participating institutions and thus have no potential conflict    of interest with study results. The DSMB is responsible for external oversight,    patient safety (adverse events), study integrity, and interim analyses (for    the possibility of early termination). It should be noted that the roles of    the DSMB differ from each participating institution's ethics board or IRB (Institutional    Review Board), who approve the ethical conduct of the study at their institution,    but typically do not monitor interim analyses given their potential institutional    conflict of interest.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><i>Coordination    level</i></font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The unique    aspect of a multi-site study is the existence and the essential need for coordination    and centralization of activities. For example, protocol development, development    of study materials, training, communication, laboratory determinations, data    processing and management, report generation, statistical analysis, and manuscript    development, are all activities that are common to any study, whether single-site    or multi-site. However, in a multi-site study, these activities are often centralized    because of the need to standardize them across all sites, which often also has    the further benefit of resulting in a gain of cost efficiency.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">However,    when the activities are centralized, the central group 'controls' the data and    hence the study; and must take steps to assure other participating institutions    that it is managing it adequately. This assurance is provided by developing    adequate systems for staff training and quality assurance, collecting, entering,    managing and analyzing the data. These activities are done by the statistical    coordinating center (CC) (<a href="#tabela1">table I</a>). In addition, it is    imperative that communication among all participating institutions be clear,    continuous, and well documented, a major task of the coordinating center. Finally,    but maybe the most important task of the centralized institutions is that of    assuring the collaboration of all study participating institutions in having    their data aggregated and shared with others. It is thus necessary that written    rules and regulations be elaborated to give equal and fair access to all participating    investigators &#150this is where governance documents are relevant (<a href="#tabela2">Table    II</a>).</font></p>     <p align="center"><a name="tabela1"></a></p>     <p align="center">&nbsp;</p>     ]]></body>
<body><![CDATA[<p align="center"><img src="/img/revistas/spm/v45n1/15051t1.gif"></p>     <p align="center"><a name="tabela2"></a></p>     <p align="center">&nbsp;</p>     <p align="center"><img src="/img/revistas/spm/v45n1/15051t2.gif"></p>     <p align="center">&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">One important    responsibility of the CC is the administrative coordination of the study. It    is the main center for communication between all participating sites, ensuring    that sites receive notification of changes to the protocol or forms, clarifications    of the manual of operations, patient safety updates, and other critical information.    The CC is also responsible for supporting study functions: meeting regulatory    requirements, producing progress reports for the study investigators and sponsor,    facilitating communications within the study, and managing data security systems.<sup>4</sup>    They also coordinate and facilitate meetings of the investigators' committees    and of external committees. The essential CC staff member for these tasks is    the project coordinator (PC), the focal person for communication and study management.    This individual is responsible for resolving questions and issues raised by    the sites, helping the site staff with data transfer, and any other aspect of    supporting the operations at the sites. Often called the data coordinator, data    manager or data specialist, (s)he is responsible for quality control of the    data; for generating edit queries and data requests; and for maintaining all    study files. The role of coordinating and maintaining communication is quite    challenging even if a multicenter study is conducted in a single country, but    it is substantially more complex in multi-national studies (<a href="/img/revistas/spm/v45n1/15051t3.gif">table    III</a>). For example, sending faxes to countries where the same phone is used    for voice as well as for fax during local office hours, cannot be automatic,    and require that the sender know the local language to communicate that a fax    is being sent. Aside from the usual difficulties with communication infrastructure    that one should expect to encounter when some of the countries are in lesser    stages of development, challenges arise when cultural differences are encountered.    Thus, in cultures that find it difficult to say 'no,' proposed changes to the    protocol by one group may not be objected to in any verbal or written communication,    but may not be carried out later by that site. In addition, language differences    complicate interactions not only in communications but also for translating    and back translating study materials.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The second    major responsibility of the CC is ensuring the quality of the data in all its    aspects: design of data collection forms, field work procedures, data entry    management systems, quality assurance procedures, data processing and editing,    and analysis and interpretation of data. The PI of the CC assumes ultimate responsibility    for the quality of the data; the determination of adequate sample size; for    defining the statistical methodology; for data analyses of the study; and is    involved in monitoring the progress of the study. The PI is a member of the    study steering committee (SC).</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Computer    programming staff at the CC are responsible for designing and creating the data    entry management system. Often, the system consists of a core common database    for all sites, with additional site-specific data modules. The core common database    is a frequent situation in multi-center studies since many of the site investigators    may not choose to collect some part of the information that others collect;    also, some questions may not be considered culturally appropriate in some settings.    Typically the data entry management systems are in a common language, while    site-specific instruments are in the local language, which may pose a problem    for site data entry operators. Programmers are also responsible for the ongoing    maintenance, including installation of software upgrades, for ensuring database    integrity and security and for maintaining an adequate backup system. It is    a challenging activity when, because of financial limitations, the various sites    have different computer set-ups, with different versions of common software,    different software, different operating systems or even different platforms.    It is also more difficult to protect such a network of computers from viruses    and to provide on-site maintenance, so that it is often more practical to have    local providers maintain the systems.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Statistical    staff at the CC are responsible for analyzing the data, including preparation    of periodic reports for monitoring progress and quality assurance, as well as    descriptive and inferential analyses of study results. When a particular study    design combines the depth of qualitative data and breath of quantitative research,    the CC should expand its staff capabilities with the addition of appropriate    social scientists to the team. These co-investigators are responsible for the    qualitative study design (sample selection, methods and techniques of data collection,    instrumentation), its quality and analyses. The nature of the analysis methodology    may require that each study site do the interpretation of their results based    on themes common across all sites but in accordance with their own cultural    distinctions.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Periodic    internal and external reports of the CC monitoring study progress must also    detail data collection irregularities, timeliness and completion of forms, data    entry errors, inconsistencies, and other aspects of quality assurance. An integral    component of quality assurance is the training of the study staff. The training    can be done by workshops, via video or internet methods, and/or with written    material. The training is important to ensure that staff understand the protocol    and the requirements of the study. Once the study is underway, continuing training    efforts may be necessary, especially if there is staff turnover. Internationally,    this is difficult to achieve from a budget standpoint, and it is often the case    that the site PI or data coordinator is trained so that that individual can    provide training for new staff ('train the trainer approach').</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Aside from    centralized coordination of data in a multicenter study, laboratory determinations    benefit from being centralized since standardization of reagents and of laboratory    procedures is easier to implement. On the other hand, difficulties lie in the    need to establish reliable (and often rapid) means of transporting the samples    to the central laboratory. Cost is an important issue, but Customs and in-transit    country restrictions on transport of human specimens need to be fully accounted    for.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">As mentioned    above, WorldSAFE has two coordinating centers, one for the India sites and one    for other countries in Temuco, Chile. The coordinating center (CC) tasks for    the India sites are actually shared among three of the seven sites, with Lucknow    serving as the CC for administrative tasks, the training activities being coordinated    by the Trivandrum site, and the statistical CC tasks performed at the Vellore    site.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The CC tasks    for WorldSAFE sites not in India are also shared among different organisms,    due to financial considerations. Thus the statistical tasks are located at the    Temuco site, the administrative tasks are performed by the team of four external    advisors, and the training tasks are provided by the external advisors. The    training for all of the WorldSAFE sites including India was provided to each    country by the same team of external advisors, and the within-country training    was provided by those trained if there were more than one site (only in India).</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Given that    there are two coordinating centers performing statistical tasks in WorldSAFE,    an additional collaboration and coordination was necessary. Thus, the data entry    software for the common data form was first developed by the Vellore CC for    all India sites, and it served as the basis for the one developed by the Temuco    CC for all other participating countries. Common data cleaning and management    procedures were developed at both CCs in co-operation with one of the external    advisors. Data files for all sites are available at both CCs, while each of    the corresponding CC is responsible for the updates to their corresponding sites'    databases. Analyses can be performed at either CC, subject to the process established    by the Steering Committee.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The lack    of funding for the CC to undertake the administrative tasks for WorldSAFE implied    that continuing education, protocol clarifications and other support of sites    was not continuous, but sporadic; it took place at the irregularly&#150spaced meetings    of investigators. Specific questions were addressed by e-mail from sites to    one of the advisors or to the CC in Temuco and other priorities hindered rapid    communication. Ad-hoc subcommittees of the SC adopted some tasks until adequate    funding for the CC is obtained.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The two    CCs of WorldSAFE, one in Vellore specifically for India and the other in Temuco,    made the communications within a region/country more efficient, but more difficult    as a whole. Given that the level of funding was not comparable between the two    CCs, the level of support each was able to provide to the sites for which they    were responsible, was not uniform. Communication and sharing of data between    the two CCs was thus more cumbersome. E-mail and internet-based communication    have kept costs down.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><i>Conduct    level</i></font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The sites    are responsible for direct interaction with the study participants, being responsible    for identifying and screening potential study participants, obtaining informed    consent, enrolling eligible study participants, collecting data (interviews),    scheduling participant visits, maximizing patients' compliance, and minimizing    loss to follow up. Sites are responsible for routine communications with the    CC in order to resolve problems with data collection and submission; and for    data transmissions. Finally, sites are responsible for complying with country    regulations and ethical guidelines. These issues include obtaining appropriate    ethical review, and complying with informed consent procedures. The site PI    is scientifically responsible and accountable for the conduct of the study and    all site activities, and is a member of the steering committee.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The site    data coordinator is responsible for collection, quality, and management of data    from the site. This person has to schedule the interviews, supervise the conduct    of interviews, supervise the interviewers and process the questionnaires/interviews.    The data coordinator is the contact person for the coordinating center's project    coordinator (PC). They interact on a very frequent basis, to keep up with the    activities of the study. At a minimum, week-to-week contact is necessary, and    this is often done via e-mail communication internationally. If a local site    handles their site-specific analyses, or if the study permits local sites to    analyze cross-site data,<sup>1</sup> sites may need to have statistical and    computer programming staff. The site statistician is usually responsible for    site-specific analyses only.</font></p>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Governance</font></b></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">One of the    special needs for any study at multiple institutions is the additional complexity    of getting a large number of investigators to collaborate and to follow a common    protocol. Single site studies may also have multiple investigators, but the    single principal investigator usually is able to exercise authority in obtaining    the necessary standardization. This is similar to a multi-site study, since    the site investigators do not have a role as participating investigators in    protocol design, nor in analyses and publications. However, in multicenter studies,    the complexity arises because of multiple principal investigators at the different    participating institutions, as well as other affiliated investigators. The main    purpose of a governance document is thus to provide written rules and regulations    by which the investigators will self-govern, with the objective of furthering    the common good.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The compendium    of guidelines for co-operation among the participating institutions of a multi-center    study is collectively called the Governance Document (GD). This may be a simple    and short document, but often it is laborious in detail and is constantly in    flux. The GD should have the approval of all sites' principal investigators.    The elements of a governance document are listed in table II. The first two    sections are primarily to specify the committee structure for the study, and    to clarify the roles and responsibilities of all involved. The next section    delineates how the institutions will interact in decision making. The two last    sections are usually the most controversial, since they involve sharing the    data (issues of access) and sharing the academic rewards of the research (issue    of publications and co-authorship). There is no perfect model, and each study    will have to struggle with setting their own guidelines, but some broad issues    to consider are mentioned below.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><i>Data    access</i></font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Access to    data in a multicenter study is more complex than data from a single-site study.    This is so because there are data that are site-specific and data that are 'common.'    The common data are pooled into an 'aggregate database' at the CC. Typical issues    that arise include: (i) who has access to the aggregated data; (ii) does site    A have access to Site B's site-specific data; (iii) if a site investigator leaves    the study, do they retain access? Does the replacement gain access; and (iv)    when do other non-study investigators gain access to the data? Who decides?</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">These decisions    are complex since they involve many decision makers. Investigators who are not    part of the study usually must submit a written proposal to gain access. Decisions    and policies are typically handled by the Publications Subcommittee, but the    ultimate policy setting authority resides with the Steering Committee.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><i>Publication    policies</i></font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The Publications    Subcommittee has the additional difficult task of setting guidelines for collaborating    on publications, other dissemination activities such as scientific and non-scientific    presentations, and co-authorship. Publication policies are established by the    Publications Subcommittee and approved by the Steering Committee. These include    policies for all presentations, abstracts, scientific publications, seminars,    press releases or other dissemination activities. Typically, local sites are    allowed to publish analyses of their site-specific and their common data; it    is also collegial courtesy to inform other study investigators of these activities.    Publications that use pooled data are more problematic. All such publications    must go through approval and follow the process established by the Publications    Subcommittee. Typical issues that arise include: (i) investigator X wants to    publish the same idea as investigator Y; (ii) investigator W does not want his/her    site's data used in a manuscript proposed by investigator Z; and (iii) investigator    S is afraid that investigator T will publish results from their site before    (s)he has a chance to publish results from his/her own site.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The above    legitimate concerns from investigators participating in a collaborative effort    are what the policies set forth in the publication guidelines should address.    The approach used in WorldSAFE is the democratic approach of allowing all investigators    to provide ideas for analyses of the common data, and allow all to have the    possibility of working on a manuscript proposed by others (non-facility in the    English language may be an impediment in some multi-national studies). Some    of these concepts may not apply well in some cultures, and fairness to all participants    may need to be sensitive to this aspect.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><i>Authorship    guidelines</i></font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Finally,    the most difficult issue is establishing rules for co-authorship. Some investigators    may assume that participating in a multi-center study guarantees that they will    be co-authors of all publications of the common data. This may not be manageable    in large studies, and unless decisions are made collectively early on in the    study, this may lead to unconstructive situations. Many scientific journals    require that only those who had substantive contributions in the writing of    the manuscript can be listed as co-authors. The decision of 'substantive contribution'    needs to be made; by whom and under what criteria, must be specified.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Guidelines    for co-authorship have also been adopted by many academic institutions, and    are based on the premise that authorship is not conferred, but earned, and that    all study participants be given equal and fair opportunities to earn the co-authorship.    Earning co-authorship requires an 'intellectual' contribution to a manuscript    as well as actual contribution to the writing of the paper. For example, solely    contributing subjects does not merit co-authorship, nor does simply performing    statistical calculations.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">All study    investigators and personnel must have the opportunity to participate in manuscripts.    The participation procedure is determined by the Publications Subcommittee.    A common approach, also used in WorldSAFE, is to form manuscript specific 'working    groups' among all those interested in a particular topic. It is typical that    in large collaborative efforts that some working groups may be quite large;    in practice, a 'facilitator' keeps the group moving towards development of the    manuscript, and typically only a few members of the group choose to actively    participate. Authors for a particular manuscript are then the actively participating    members of the manuscript working group. Also, authorship order is based upon    their relative contribution to the manuscript. Definitions of 'actively,' 'substantive,'    and 'intellectual' contributions are usually specified by the Publications Subcommittee,    and involve more than revising drafts for grammar and typographical errors,    for example. Publications guidelines include also acknowledgements guidelines    for sites, the coordinating center, and other study participants.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">When data    are collected at many sites and in different countries, it is typically expected    that all manuscripts would have representation at least from each country, but    the method suggested above does not guarantee this. The above method implies    that each investigator needs to earn their co-authorship in every manuscript.    Investigators that are culturally 'passive collaborators' may be affected by    the above method. Also, in a collaborative effort, a particular manuscript may    not include data from a particular site, but the investigators from that site    are permitted to join the working group if interested. It may also occur that    data from a site are used in a particular manuscript and no one from that site    is a co-author; in such a case the site is typically acknowledged only. If a    site refuses to have their data shared, the collaboration fails.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">While the    suggested publication policies above may sound harsh and some investigators    may feel they are 'not necessary, since we are all collegial friends,' they    are meant to ensure that all study members have the same opportunity to participate    in presentations and publications, fairly.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">When the    common data reside at the CC in another country, Investigator X in a different    country may not feel that he or she has the same access as an investigator at    the CC and a copy of the analyses files may be sent to each site for exploratory    analyses. However, it is in the best interest of a multi-center study that final    statistical analyses for manuscripts be centralized at the CC, to assure use    of the latest updated and corrected files, and the use of standard data procedures    across the study. However, distributed data analyses may lead to more publications    if the centralized resources are not adequate.<sup>5</sup> Internationally,    access to data is a challenge for rapid interaction, discussion, conducting    statistical analyses, reviewing results, and so forth. Recent advances in communication    technology have made this more possible. For example, it is now possible to    use the internet and with password protection, have specific access to servers    and web pages, to communicate, download data, post analyses results, and drafts    of manuscripts for participants anywhere to be able to interact in developing    publications.</font></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">WorldSAFE's    experience with governance has been mixed. Antagonistic issues have not arisen    to test the governance document. Collaborative publications have not been hindered    by conflicts, but more from lack of time and other priorities for investigators    with limited funding support.</font></p>     <p>&nbsp;</p>     <p><b><font size="3" face="Verdana, Arial, Helvetica-Normal, sans-serif">Discussion</font></b></p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The issues    presented in this manuscript are ones that must be considered in the planning    of health studies internationally. The issues raised must be adapted to the    specific circumstances of any particular project. Cultural sensitivities are    important considerations, and these especially impact governance methods adopted    by the project. From a rigor standpoint, one must be flexible but still attend    to the methodological considerations for proper planning and conduct of international    collaborative efforts in health research. The experience of the WorldSAFE study    leads to a few recommendations. Effective international communication and coordination    is best done with a single coordinating center that assumes scientific responsibility    for the overall study data. Regional coordinating centers or country-specific    coordinating centers can provide more immediate support to local sites, but    they in turn should be coordinated by one adequately-funded center.</font></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><b><font size="3" face="Verdana, Arial, Helvetica-Normal, sans-serif">References</font></b></p>     <!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">1. International    Clinical Epidemiology Network 2000; WorldSAFE and IndiaSAFE. Studying the prevalence    of family violence, Philadelphia (PA): INCLEN Monograph Series on Critical International    Health Issues No. 9.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9166552&pid=S0036-3634200300010000800001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">2. Mowery    RL, Williams OD. Aspects of clinic monitoring in large-scale multiclinic trials.    Clin Pharmacol Ther 1979;25:717-719.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9166553&pid=S0036-3634200300010000800002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">3. Bangdiwala    SI, Paton CC, Jackson MR. Clinic monitoring in collaborative clinical studies.    En:Okuno T, ed. Biometry. Clinical trials and related topics. Amsterdam: Excerpta    Medica, 1988:37-46.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9166554&pid=S0036-3634200300010000800003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">4. Blumenstein    BA, James KE, Lind BK, Mitchell HE. Functions and organization of coordinating    centers for multicenter studies. Controlled Clin Trials 1995;16:4s-29s.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9166555&pid=S0036-3634200300010000800004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">5. Perkins    LL, Cutter GR, Wagenknecht LE, Savage PJ, Dyer AR, Birch R. Distributed data    analysis in a multicenter study: The CARDIA Study. Controlled Clin Trials 1992;13:80-90.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=9166556&pid=S0036-3634200300010000800005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><b>Address    requests to:    <br>   </b>Shrikant I. Bangdiwala    ]]></body>
<body><![CDATA[<br>   PhD, Department of Biostatistics-CSCC, 137 E    <br>   Franklin Street, Suite 203 Chapel Hill    <br>   NC 27514-4145 USA    <br>   E-mail: <a href="mailto:kant@unc.edu">kant@unc.edu</a></font></p>     <p><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">Received    on:</font></b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">    September 12, 2001    <br>   <b>Accepted on:</b> December 8, 2002    <br>   </font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The    work presented here was partially supported by International Clinical Epidemiology    Network (INCLEN) grant # CBS 99-001 and by the Chilean "Fondo Nacional de Desarrollo    Cient&iacute;fico y Tecnol&oacute;gico" (FONDECYT) grant # 1000232.</font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">The English    version of this paper is available too at: <a href="http://www.insp.mx/salud/index.html">http://www.insp.mx/salud/index.html    ]]></body>
<body><![CDATA[<br>   </a></font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><a name="back1"></a><a href="#top1">1</a>    University of North Carolina, Chapel Hill, NC, USA    <br>   </font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><a name="back2"></a><a href="#top1">2</a>    Escola Paulista de Medicina, Universidade Federal de S&atilde;o Paulo, S&atilde;o    Paulo, Brazil    <br>   </font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><a name="back3"></a><a href="#top1">3</a>    University of the Philippines, Manila, The Philippines    <br>   </font><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><a name="back4"></a><a href="#top1">4</a>    Universidad de La Frontera, Temuco, Chile</font></p>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>International Clinical Epidemiology Network 2000</collab>
<collab>WorldSAFE and IndiaSAFE</collab>
<source><![CDATA[Studying the prevalence of family violence]]></source>
<year></year>
<volume>9</volume>
<publisher-loc><![CDATA[Philadelphia^ePA PA]]></publisher-loc>
<publisher-name><![CDATA[INCLEN Monograph Series on Critical International Health Issues]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mowery]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[OD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Aspects of clinic monitoring in large-scale multiclinic trials]]></article-title>
<source><![CDATA[Clin Pharmacol Ther]]></source>
<year>1979</year>
<volume>25</volume>
<page-range>717-719</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bangdiwala]]></surname>
<given-names><![CDATA[SI]]></given-names>
</name>
<name>
<surname><![CDATA[Paton]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Clinic monitoring in collaborative clinical studies]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Okuno]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Biometry: Clinical trials and related topics]]></source>
<year>1988</year>
<page-range>37-46</page-range><publisher-loc><![CDATA[Amsterdam ]]></publisher-loc>
<publisher-name><![CDATA[Excerpta Medica]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blumenstein]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
<name>
<surname><![CDATA[Lind]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Mitchell]]></surname>
<given-names><![CDATA[HE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Functions and organization of coordinating centers for multicenter studies]]></article-title>
<source><![CDATA[Controlled Clin Trials]]></source>
<year>1995</year>
<volume>16</volume>
<page-range>4s-29s</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perkins]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Cutter]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
<name>
<surname><![CDATA[Wagenknecht]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Savage]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Dyer]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Birch]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Distributed data analysis in a multicenter study: The CARDIA Study]]></article-title>
<source><![CDATA[Controlled Clin Trials]]></source>
<year>1992</year>
<volume>13</volume>
<page-range>80-90</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
